Cited by 217Central Venous Catheters and HemodialysisIntravenous Infusion Technology and SafetyHemodynamic Monitoring and Therapy

Safety of peripheral intravenous administration of vasoactive medication

Cardenas‐Garcia, Jose, Schaub, Karen F., Belchikov, Yuly G., Narasimhan, Mangala, Koenig, Seth J., Mayo, Paul H.·2015·Journal of Hospital Medicine

Abstract

BACKGROUND: Central venous access is commonly performed to administer vasoactive medication. The administration of vasoactive medication via peripheral intravenous access is a potential method of reducing the need for central venous access. The aim of this study was to evaluate the safety of vasoactive medication administered through peripheral intravenous access. METHODS: Over a 20‐month period starting in September 2012, we monitored the use of vasoactive medication via peripheral intravenous access in an 18‐bed medical intensive care unit. Norepinephrine, dopamine, and phenylephrine were all approved for use through peripheral intravenous access. RESULTS: A total of 734 patients (age 72 ± 15 years, male/female 398/336, SAPS II score 75 ± 15) received vasoactive medication via peripheral intravenous access 783 times. Vasoactive medication used was norepinephrine (n = 506), dopamine (n = 101), and phenylephrine (n = 176). The duration of vasoactive medication via peripheral intravenous access was 49 ± 22 hours. Extravasation of the peripheral intravenous access during administration of vasoactive medication occurred in 19 patients (2%) without any tissue injury following treatment, with local phentolamine injection and application of local nitroglycerin paste. There were 95 patients (13%) receiving vasoactive medication through peripheral intravenous access who eventually required central intravenous access. CONCLUSIONS: Administration of norepinephrine, dopamine, or phenylephrine by peripheral intravenous access was feasible and safe in this single‐center medical intensive care unit. Extravasation from the peripheral intravenous line was uncommon, and phentolamine with nitroglycerin paste were effective in preventing local ischemic injury. Clinicians should not regard the use of vasoactive medication is an automatic indication for central venous access. Journal of Hospital Medicine 2015;10:581–585. © 2015 Society of Hospital Medicine

Integrity signals

Registry

Crossref · 10.1002/jhm.2394

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cardenas‐Garcia, J., Schaub, K. F., Belchikov, Y. G., Narasimhan, M., Koenig, S. J., & Mayo, P. H.
Affiliations
  • Division of Pulmonary Critical Care and Sleep Medicine Hofstra North Shore–Long Island Jewish School of Medicine Hempstead New York
  • Hofstra University (US)
  • Westchester Medical Center (US)
Venue
Journal of Hospital Medicine
Publisher
Wiley
Published
2015-05-26
Volume
10
Issue
9
Pages
581-585
ISSN
  • 1553-5592 (ISSN-L)
  • 1553-5606
OpenAlex
W1962642315
Cited by
217
References
20
Citations by year
2026: 13 · 2025: 20 · 2024: 33 · 2023: 18 · 2022: 21 · 2021: 30 · 2020: 25 · 2019: 29 · 2018: 13 · 2017: 8 · 2016: 6 · 2015: 1
FWCI
16.10
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hospital Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Health Professions › Emergency Medical Services › Central Venous Catheters and Hemodialysis
  • Physical Sciences › Engineering › Biomedical Engineering › Intravenous Infusion Technology and Safety
  • Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
Keywords
peripheral intravenous access, vasoactive drugs, norepinephrine, dopamine, phenylephrine, extravasation, phentolamine, central venous access, intensive care unit, hemodynamic support
MeSH terms
Aged, Aged, 80 and over, Cardiotonic Agents, Catheterization, Peripheral, Dopamine, Female, Humans, Infusions, Intravenous, Intensive Care Units, Male, Middle Aged, Norepinephrine, Phenylephrine, Vasoconstrictor Agents, Patient Safety, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review